🔗 Share this article

Treasury head Reeves has announced she is preparing "focused measures to tackle household expense challenges" in the forthcoming Budget.

During an interview with the BBC, she emphasized that reducing price rises is a collective task of both the government and the central bank.

The UK's inflation rate is expected to be the highest among the G7 industrialized countries this year and the following year.

Potential Utility Bill Measures

Sources suggest the administration could take action to bring down utility costs, for example by cutting the present 5% rate of value-added tax applied on energy.

Another possibility is to reduce some of the regulatory levies currently added to household expenses.

Budgetary Constraints and Analyst Predictions

The government will obtain the next assessment from the independent fiscal watchdog, the Office for Budget Responsibility, on the start of the week, which will clarify how much room there is for such actions.

The consensus from the majority of experts is that the Chancellor will have to announce tax rises or expenditure reductions in order to adhere to her voluntary fiscal targets.

Previously on Thursday, estimates indicated there was a £22bn gap for the chancellor to fill, which is at the more modest range of forecasts.

"There's a joint job between the central bank and the administration to bear down further on some of the causes of inflation," the Chancellor informed reporters in the US capital, at the conferences of the IMF and World Bank.

Tax Commitments and Global Concerns

While much of the focus has been on likely tax increases, the Treasury chief said the latest information from the fiscal watchdog had not altered her pledge to campaign commitments not to increase tax levels on earnings tax, sales tax or National Insurance.

She attributed an "uncertain world" with increasing geopolitical and commercial concerns for the Budget tax moves, likely to be targeted on those "with the broadest shoulders."

Global Economic Disputes

Commenting on worries about the United Kingdom's economic relations with China she said: "Our security interests invariably take priority."

Last week's announcement by China to strengthen export controls on rare earths and other materials that are crucial for advanced tech production led American leader the US President to suggest an further 100% tariff on imports from China, raising the risk of an full-scale trade war between the two global powers.

The US Treasury Secretary labeled the Chinese move "commercial pressure" and "a international production control attempt."

Asked about accepting the American proposal to join its dispute with China, Reeves said she was "deeply worried" by Chinese measures and encouraged the Chinese government "not to put up barriers and restrict access."

She said the move was "bad for the international commerce and causes additional obstacles."

"I believe there are fields where we need to challenge China, but there are also important opportunities to sell into China's economy, including banking sector and other areas of the economy. We've got to achieve that equilibrium correct."

The Treasury chief also confirmed she was working with international partners "on our own essential resources approach, so that we are less reliant."

NHS Drug Pricing and Funding

The Chancellor also acknowledged that the price the National Health Service spends on medicines could rise as a result of ongoing negotiations with the Trump administration and its drugs companies, in return for lower tariffs and funding.

A number of the biggest global pharmaceutical manufacturers have said recently that they are either halting or canceling investments in the UK, with some blaming the low prices they are obtaining.

Last month, the government science advisor said the price the health service pays for medicines would have to rise to stop companies and pharmaceutical investment leaving the UK.

The Chancellor stated to media: "It has been observed due to the cost structure, that drug testing, recent pharmaceuticals have not been provided in the United Kingdom in the extent that they are in other continental states."

"We want to ensure that patients getting treatment from the National Health Service are can access the finest essential drugs in the globe. And so we are looking at these issues, and... looking to obtain increased capital into Britain."